articleTop 1% cited

Pregnancy Outcomes in Solid Organ Transplant Recipients With Exposure to Mycophenolate Mofetil or Sirolimus

Transplantation · 2006 · Vol. 82(12) · pp. 1698–1702

Nicole M. Sifontis(Temple University)Lisa Coscia(Weatherford College)S Constantinescu(Temple University)Antonella LavelanetMichael J. Moritz(Lehigh Valley Hospital-Pocono)Vincent T. Armenti✉(Temple University)

View via DOI Publisher page

Abstract

A higher incidence of structural malformations was seen with MMF exposures during pregnancy compared to the overall kidney transplant recipient offspring, while no structural defects have as yet been reported with early pregnancy sirolimus exposures. Centers are encouraged to report all pregnancy exposures in transplant recipients.

Pregnancy and Medication Impact Organ and Tissue Transplantation Research Neurological Complications and SyndromesMedicinePregnancyOffspringSirolimusMycophenolic acidObstetricsTransplantationKidney transplantationSurgery

MeSH terms

Abnormalities, Drug-InducedAdultFemaleHumansImmunosuppressive AgentsMaternal-Fetal ExchangeMycophenolic AcidPregnancyPregnancy OutcomeRegistriesOrgan TransplantationMaternal ExposureSirolimus

Citations

445

FWCI

21.24

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients